Programmed Death 1 Ligand (PD-L) 1 and PD-L2 Limit Autoimmune Kidney Disease: Distinct Roles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Programmed Death 1 Ligand (PD-L) 1 and PD-L2 Limit Autoimmune Kidney Disease: Distinct Roles

Published:2007-11-19 Issue:11 Volume:179 Page:7466-7477
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Menke Julia,Lucas Julie A.,Zeller Geraldine C.,Keir Mary E.,Huang Xiao R.,Tsuboi Naotake,Mayadas Tanya N.,Lan Han Y.,Sharpe Arlene H.,Kelley Vicki R.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis

2. Nephritogenic cytokines and disease in MRL-Fas kidneys are dependent on multiple T-cell subsets

3. Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury

4. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

5. THE B7 FAMILY REVISITED

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury associated with anti-PD-1 and anti-PD-L1 drugs: a meta-analysis of randomized clinical trials;Immunopharmacology and Immunotoxicology;2024-06-02

2. Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development;Blood Journal;2023-12-24

3. All-cause and immune checkpoint inhibitor–associated acute kidney injury in immune checkpoint inhibitor users: a meta-analysis of occurrence rate, risk factors and mortality;Clinical Kidney Journal;2023-11-28

4. Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy;Molecular and Cellular Probes;2023-06

5. Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics;Drug Discovery Today;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3